Skip to main content
Signal8

Chen Hubert C

SEC insider (Form 3/4/5 filer). CIK 0001622297. Chief Medical Officer at Viking Therapeutics, Inc. (VKTX). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.

Companies Chen Hubert C has filed insider reports for

  • Viking Therapeutics, Inc. (VKTX): Officer, Chief Medical Officer
Chen Hubert C profile photo

Chen Hubert C

CIK: 0001622297

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Viking Therapeutics, Inc. logo
VKTX

Viking Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Viking Therapeutics, Inc. logo
    VKTX

    Viking Therapeutics, Inc.

    Jun 1, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    190K shares-

1-1 of 1